Peer-review Journals On Cardiogenic Shock
The clinical definition of shock is decreased flow and evidence of tissue hypoxia within the presence of adequate intravascular volume. Shock is that the leading explanation for death in acute myocardial infarction (MI), with mortality rates as high as 70-90% within the absence of aggressive, highly experienced technical care. Cardiogenic shock (CS) may be a common explanation for mortality, and management remains challenging despite advances in therapeutic options. Cardiogenic shock is caused by severe impairment of myocardial performance that results in diminished cardiac output, end‐organ hypoperfusion, and hypoxia. Clinically this presents as hypotension refractory to volume resuscitation with features of end‐organ hypoperfusion requiring pharmacological or mechanical intervention. Acute myocardial infarction (MI) accounts for 81% of patient in Cardiogenic shock, The blockage of the arteries and Blood vessels which provide oxygen and nutrient rich blood to heart. It is also called coronary heart disease and is the leading cause of death in humans. This occurs when the coronary arteries become blocked or clogged, often this leads to an irregular heartbeat - called an arrhythmia - that causes a severe decrease in the pumping function of the heart. A blockage that's not treated within a couple of hours causes the affected cardiac muscle to die.
High Impact List of Articles
-
An infrequent association: Left ventricular non compaction with bicuspid aortic valve and coarctation of the aorta.
Aureo Campos-Tello, Giancarlo A Valle, Felix A Revilla, Sara Ramirez-Flores, ngel CuevaParra, Zoila Rodriguez-UrteagaCase Report: Current Trends in Cardiology
-
4th World Congress on Cardiology and Cardiac Nursing Held on March 23-24, 2020 at London, UK Awards for Cardiology and Cardiac Nursing
Sergey SuchkovAwards 2020: Current Trends in Cardiology
-
Current understanding of the electrocardiographic manifestations of the
?athlete?s heart?.
Gemma Parry-Williams, Sanjay SharmaReview Article: Current Trends in Cardiology
-
Do DPP-4 inhibitors improve endothelial cell function?
Hiroshi Nomoto, Hideaki Miyoshi, Akinobu Nakamura, Tatsuya Atsumi, Naoki Manda, Yoshio Kurihara, Shin AokiShort Communication: Current Trends in Cardiology
-
Genetics of coronary artery disease
Fan WangEditorial: Current Trends in Cardiology
Conference Proceedings
-
The mysteries of S6K2 may shed light to Breast Cancer Therapy path
Nurettin İlter Sever -
The mysteries of S6K2 may shed light to Breast Cancer Therapy path
Nurettin İlter Sever -
New fiber reinforced composite material for custom-made craniofacial implants
Lazar MAPosters & Accepted Abstracts: Biomedical Research
-
New fiber reinforced composite material for custom-made craniofacial implants
Lazar MAPosters & Accepted Abstracts: Biomedical Research
-
ANTI-HYPERGLYCEMIC ACTION OF GYNURA PROCUMBENS IS PARTLY MEDIATED BY INHIBITION OF CARBOHYDRATE DIGESTION AND ABSORPTION IN THE GUT
Kazi Ishtiaq Ahmad, Mahbub Hasan, Limu Parvin, Afra Haque, Kamol Krishna Nandy and JMA HannanScientific Tracks Abstracts: Biomedical Research
-
ANTI-HYPERGLYCEMIC ACTION OF GYNURA PROCUMBENS IS PARTLY MEDIATED BY INHIBITION OF CARBOHYDRATE DIGESTION AND ABSORPTION IN THE GUT
Kazi Ishtiaq Ahmad, Mahbub Hasan, Limu Parvin, Afra Haque, Kamol Krishna Nandy and JMA HannanScientific Tracks Abstracts: Biomedical Research
-
BIO-ANALYTICAL METHODS FOR QUANTITATIVE DETERMINATION (BIO-EQUIVALENCE AND BIO-AVAILABILITY) OF DRUG PRESENT IN THE BLOOD MATRIX
Aashna Lamba and Swastika MishraPosters & Accepted Abstracts: Asian Journal of Biomedical and Pharmaceutical Sciences
-
BIO-ANALYTICAL METHODS FOR QUANTITATIVE DETERMINATION (BIO-EQUIVALENCE AND BIO-AVAILABILITY) OF DRUG PRESENT IN THE BLOOD MATRIX
Aashna Lamba and Swastika MishraPosters & Accepted Abstracts: Asian Journal of Biomedical and Pharmaceutical Sciences
-
HARNESSING PHYTOCHEMICALS TO SUPPORT THE NERVOUS SYSTEM
Anat Elmann -
HARNESSING PHYTOCHEMICALS TO SUPPORT THE NERVOUS SYSTEM
Anat Elmann